LGALS4 and breast carcinoma: In advanced breast cancer treatment, PEA-15 was targeted by a breast cancer construct, T-VISA, composed of the human telomerase reverse transcriptase (hTERT; T) promoter and a versatile transgene amplification vector VISA (VP16-GAL4-WPRE integrated systemic amplifier).